Background
Methods
Study design and methodological framework
Literature selection
Data collection strategies
Data analysis process
Data extraction
Data analysis
Rank | Keyword
| |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Frequency | TF-IDF | Degree centrality | closeness centrality | Betweenness centrality | ||||||
word | value | word | value | word | value | word | value | word | value | |
1 | cell | 7653 | cell | 17,310
| effect | 1.000 | effect | 1.000 | effect | 0.0015 |
2 | patient | 6910 | effect | 17,190 | treatment | 1.000 | treatment | 1.000 | treatment | 0.0015 |
3 | treatment | 6851 | cancer | 16,860 | study | 1.000 | study | 1.000 | study | 0.0015 |
4 | cancer | 6722 | patient | 15,582 | analysis | 1.000 | analysis | 1.000 | analysis | 0.0015 |
5 | study | 6295 | treatment | 15,520 | disease | 1.000 | disease | 1.000 | disease | 0.0015 |
6 | effect | 6203 | study | 14,777 | approach | 1.000 | approach | 1.000 | approach | 0.0015 |
7 | analysis | 3618 | analysis | 10,456 | model | 0.995 | factor | 1.000 | factor | 0.0015 |
8 | disease | 3390 | disease | 10,071 | patient | 0.990 | model | 0.995 | model | 0.0014 |
9 | trial | 3244 | trial | 9789 | activation | 0.990 | patient | 0.990 | type | 0.0014 |
10 | review | 2948 | review | 9115 | use | 0.990 | activation | 0.990 | activation | 0.0014 |
11 | model | 2411 | activation | 9071 | evaluation | 0.990 | use | 0.990 | patient | 0.0014 |
12 | activity | 2397 | model | 7936 | drug | 0.985 | evaluation | 0.990 | use | 0.0014 |
13 | drug | 2258 | case | 7817 | cell | 0.980 | type | 0.990 | drug | 0.0014 |
14 | use | 2232 | mice | 7809 | review | 0.975 | drug | 0.985 | evaluation | 0.0014 |
15 | efficacy | 2156 | drug | 7742 | case | 0.975 | response | 0.985 | review | 0.0014 |
16 | case | 2117 | use | 7558 | cancer | 0.970 | cell | 0.980 | strategy | 0.0014 |
17 | inhibition | 1991 | inhibition | 6979 | management | 0.965 | strategy | 0.980 | role | 0.0014 |
18 | management | 1870 | management | 6632 | trial | 0.960 | review | 0.975 | development | 0.0014 |
19 | health | 1731 | health | 6407 | inhibition | 0.960 | case | 0.975 | response | 0.0013 |
20 | breast | 1679 | breast | 6202 | health | 0.920 | system | 0.975 | application | 0.0013 |
Literature review
Key word rank | Topics | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | |
Expert Topic Classification | Medicine | Medicine | Medicine | Nursing | Medicine | Medicine | Nursing | Pharmacology | Medicine | Pharmacology | Medicine | Medicine | Medicine | Medicine | Medicine |
1 | model | cell | infection | trial | treatment | type | role | case | syndrome | mice | cancer | analysis | patient | effect | disorder |
2 | pathway | stem | quality | effect | use | diabetes | survey | health | impact | drug | breast | review | study | wound | extract |
3 | cell | strategy | risk | yoga | covid | application | practice | women | production | system | tumor | meta | disease | acid | mechanism |
4 | activation | tissue | life | treatment | children | protein | evidence | care | liver | nanoparticle | inhibition | intervention | outcome | injury | stress |
5 | beta | line | patient | radiation | combination | approach | failure | management | agent | delivery | factor | function | experience | research | people |
6 | signaling | method | virus | phage | stimulation | evaluation | utilization | pain | assessment | alpha | lung | development | safety | bone | effect |
7 | apoptosis | characterization | implications | protocol | gene | profile | heart | report | synthesis | effect | response | protocol | year | healing | spectrum |
8 | inflammation | cord | alzheimer | anxiety | pregnancy | diagnosis | students | perspective | body | arthritis | cell | transplantation | imaging | hiv | activation |
9 | lymphoma | decoction | control | dose | prevention | blood | cam | surgery | properties | peptide | chemo | effect | term | skin | post |
10 | hypertension | transplantation | sleep | zinc | pandemic | plasma | education | treatment | time | metabolism | expression | leukemia | center | brain | communication |
11 | mise | differentiation | tract | symptoms | vitamin | lipid | healthcare | survival | kidney | learning | growth | network | results | pressure | staphylococcus |
12 | effect | regeneration | deficiency | depression | nerve | status | valve | series | laser | oil | resistance | stroke | cohort | colitis | fibrosis |
13 | glioblastoma | serum | oxygen | placebo | design | muscle | knowledge | literature | prevalence | tool | receptor | osteoarthritis | effect | comparison | epilepsy |
14 | obesity | activation | reality | acupuncture | validation | performance | communication | oncology | compounds | changes | target | decision | data | injection | benefits |
15 | group | blood | protein | feasibility | approach | challenges | narrative | sars | screening | administration | regulation | knee | bowel | treatment | weight |
16 | diet | gamma | withdrawal | training | gut | bladder | practitioners | program | characterization | psoriasis | prostate | treatment | exercise | trends | animal |
17 | induction | matrix | era | insights | adults | surface | attitudes | rna | information | activation | splicing | relationship | hospital | cost | bacteria |
18 | AKT | vesicles | hepatitis | toxicity | microbiota | vaccine | nursing | massage | species | peptidase | kinase | update | parkinson | dysfunction | self |
19 | death | adipose | lifestyle | mri | asthma | detection | perceptions | society | immunity | damage | melanoma | music | pilot | exposure | autism |
20 | proliferation | food | response | emergency | effect | antibiotics | pseudomonas | test | stage | foot | progression | parents | rehabilitation | level | integration |
First author (yr) | Region | Study Design | Sample | Intervention | Statistics | Outcome | MMAT Quality Assessment | |||
---|---|---|---|---|---|---|---|---|---|---|
Subject type | Total Size | Category | Dependent | Measurement | ||||||
A1 | Abdulah (2021) | Turkey | Descriptive | Medical team | 794 | NA | • Independent t-test • ANOVA • Turkey post hoc test | • Knowledge • Attitude • Use degree | • Holistic complementary and alternative medicine questionnaire | • Moderate quality • (4/5 criteria met) |
A2 | Ayfer (2021) | Australia | RCT | Nursing student | 75 | Yoga | • Independent t-test | • Mental symptom • Cortisol | • Brief symptom inventory • Electrochemiluminescence immunoassay | • Moderate quality • (4/5 criteria met) |
A3 | Emilie (2021) | Germany | Quasi (pre-post) | Medical team | 82 | Education | • Descriptive • Independent t-test • χ2 test • Bonferroni | • Knowledge • Attitude • Preparation • Clinical nursing practice | • The tool developed by the researcher | • Low quality • (3/5 criteria met) |
A4 | Ezgi (2019) | Germany | RCT | Brest cancer pt | 60 | Music | • Independent t-test • χ2 test • ANCOVA | • Anxiety • Comfortable | • Hospital anxiety and depression scale • Radiation therapy comfortable survey | • High quality • (5/5 criteria met) |
A5 | Jeanene (2023) | United states of america | Quasi (pre-post) | Cancer Pt | 82 | Yoga | • Independent t-test | • Fatigue • Pain • Anxiety • Stress | • The tool developed by the researcher | • Moderate quality • (4/5 criteria met) |
A6 | Jennifer (2023) | United states of america | Quasi (pre-post) | Nurse | 23 | Education | • Descriptive | • Prevalence • Treatment • Knowledge | • The tool developed by the researcher | • Moderate quality • (4/5 criteria met) |
A7 | Judith (2020) | United states of america | RCT | HTN Pt | 69 | Acupressure | • Independent t-test • χ2 test • Cohen’s D • RM ANOVA | • Pain • Quality of life | • McGill pain questionnaire • Seattle angina questionnaire-7 | • Moderate quality • (4/5 criteria met) |
A8 | Lei (2022) | United kingdom | RCT | TA PTST Pt (women) | 94 | Yoga | • Independent t-test • χ2 test • Cohen’s D • RM ANOVA | • PTSD symptom • Depression • Anxiety | • Impact of event scale-revised • Depression anxiety stress scales-21 | • Moderate quality • (4/5 criteria met) |
A9 | Lyndall (2021) | United kingdom | Descriptive | Midwife | 571 | NA | • Descriptive • Independent t-test • χ2 test • ANOVA | • Knowledge • Training degree • type • Confidence • Competence | • The tool developed by the researcher | • Moderate quality • (4/5 criteria met) |
A10 | Özgür (2023) | Turkey | Descriptive | Nurse | 122 | NA | • Descriptive • Independent t-test • χ2 test • ANOVA • Correlation | • Knowledge • Attitude | • The tool developed by the researcher | • Low quality • (3/5 criteria met) |
A11 | Sandra (2021) | United states of america | Descriptive | Nurse | 458 | NA | • Descriptive • Independent t-test • χ2 test • Fisher’s exac test • ANOVA • Correlation | • Knowledge • Attitude • Belief • Use degree | • The tool developed by the researcher | • Moderate quality • (4/5 criteria met) |
A12 | Wendy (2020) | United kingdom | Qualitative | Naturopaths | 21 | NA | • Theme | • Role • Treatment method | • Survey • Interview | • High quality • (5/5 criteria met) |
First author (yr) | Region | Study Design | Sample | Intervention | Statistics | Outcome | MMAT Quality Assessment | |||
---|---|---|---|---|---|---|---|---|---|---|
Subject type | Total Size | Category | Dependent | Measurement | ||||||
B1 | Ahmad (2022) | Hong Kong | RCT | Peripheral artery disease Pt | 30 | Acupuncture (laser) | • McNemar–Bowker Test • Regression • MANOVA | • Blood flow • Pain | • Edinburgh claudication questionnaire • 6-min walk distance | • Moderate quality • (4/5 criteria met) |
B2 | Anjana (2020) | India | RCT | Hypertension Pt | 80 | OM chantinf and yoga | • RM ANOVA • Paired t-test • Independent t-test | • Depression • Anxiety • Stress • Sleep | • Depression anxiety stress scale • Pittsburgh sleep quality index • Heart rate variability | • Moderate quality • (4/5 criteria met) |
B3 | Chunhui (2022) | China | RCT | Crohn's Pt | 66 | Acupuncture and moxibustion | • Independent t-test • χ2 test • ANOVA • Fisher’s exact test | • Clinical mortality rate • Clinical response rate • Crohn’s disease activity Index and average change in serum c-reactive protein • Steroid-free remission rate • Average change in crohn’s disease endoscopic index of severity score and histopathological score, and the recurrence cumulative rate | • Crohn’s disease activity index • C-reactive protein • Crohn’s disease endoscopic index of severity • Histopathological score • Fecal calprotectin • Operational taxonomic unit • Linear discriminant analysis effect size | • Low quality • (3/5 criteria met) |
B4 | Conway (2021) | United states of america | Quasi (pre-post) | Hemodialysis Pt | 11 | Beathing in yoga | • Paired t-test • Wilcoxon • RM ANOVA | • Depression • Anxiety • Quality of life | • Anxiety, depression of survey • Kidney Disease Quality of Life-36 Questionnaire | • High quality • (5/5 criteria met) |
B5 | Dehghan (2021) | China | RCT | Human immunodeficiency virus Pt | 50 | Dietary therapy (green tea capsule) | • Generalized linear model • Independent t-test • Fisher’s exact test • Mann–Whitney U test | • Depression | • Hamilton depression scale • Cluster of differentiation 4 cell numbness | • Moderate quality • (4/5 criteria met) |
B6 | Hai (2019) | United states of america | RCT | After stroke depression Pt | 208 | Acupuncture | • Descriptive • Independent t-test • χ2 test • Wilcoxon • ANOVA | • Depression | • Hamilton depression scale • Self rating depression scale • National institute of health stroke scale • Modified barthel index • Treatment emergent symptom scale • Traditional chinese medicine • stroke diagnosis and evaluation criteria • Clinical global impression • Proton magnetic resonance spectroscopy • Serum | • Moderate quality • (4/5 criteria met) |
B7 | Hamidreza (2020) | United states of america | RCT | Carpal tunnel syndrome Pt | 60 | Acupuncture | • Paired t-test • Independent t-test • χ2 test • ANOVA | • Pain, numbness, tingling, weakness/clumsiness and night awakenings • Distal motor latency, distal sensory latency, sensory nerve action potential and compound muscle action potential | • Symptom survey • Electrodiagnostic studies | • High quality • (5/5 criteria met) |
B8 | Huan (2022) | United kingdom | RCT | Pelvic organ prolapse Pt | 160 | Acupuncture (electro acupuncture) | • Independent t-test • Regression | • Pelvic organ prolapse symptom | • Pelvic floor distress inventory-short form 20 • Pelvic floor impact questionnaire-short form 7 • Pelvic organ prolapse/urinary incontinence sexual questionnaire-short form 12 • International consultation on incontinence questionnaire-urinary incontinence short form • International consultation on incontinence questionnaire-lower urinary tract symptoms quality of life • Patient global impression of improvement • Patient global impression of severity • Patient satisfaction scale | • Moderate quality • (4/5 criteria met) |
B9 | Jianya (2022) | China | RCT | Insomnia Pt | 126 | Taichi therapeutic exercise | • Cochran-Mantel–Haenszel • ANOVA • ANCOVA | • Insomnia | • Pittsburgh sleep quality index • Hamilton anxiety scale • Deneralized anxiety disorder 7-item scale • Insomnia seceruty index | • High quality • (5/5 criteria met) |
B10 | Jo (2018) | United kingdom | RCT | Dementia Pt | 60 | Aroma massage | • RM ANOVA | • Behavioral and psychological symptoms • Activities of daily living • Cognitive function • Pain | • Cohen-mansfield agitation inventory • Neuropsychiatric inventory • Mini-mental state examination • Barthel Index-20 | • High quality • (5/5 criteria met) |
B11 | Kang (2023) | United states of america | RCT | Parkinson's disease pt | 80 | Acupuncture | • Independent t-test • ANOVA • Regression • RM ANOVA | • Depression | • Beck depression inventory • Parkinson’s disease sleep scale • State-trait anxiety inventory • The korean version of the fatigue, resistance, ambulation, illnesses, and loss of weight questionnaire scale • Unified parkinson’s disease rating scale III • Functional near-infrared spectroscopy • Health related quality of life • European quality of life visual analogue scale | • High quality • (5/5 criteria met) |
B12 | Katharina (2023) | United kingdom | RCT | Depression Pt | 156 | Cognitive behavioral therapy | • Katharina luttenberger | • Depressive symptom severity | • Montgomery-asberg depression rating scale • Patient Health questionnaire | • High quality • (5/5 criteria met) |
B13 | Lih (2021) | Germany | RCT | Irritable bladder syndrome Pt | 66 | Meridian point patch | • Independent t-test • Fisher’s exact test • χ2 test | • Irritable bladder syndrome | • Overactive bladder symptom score • Bladder awareness • Intensity of urgency scale • Residual urine | • High quality • (5/5 criteria met) |
B14 | Ling (2022) | United kingdom | RCT | After stroke depression Pt | 56 | Acupuncture | • Descriptive • χ2 test • ANOVA • Mann–Whitney U test • Linear mixed model | • Depression | • Hamilton depression scale-17 • Wisconsin card sorting test • Event-related potentials | • Moderate quality • (4/5 criteria met) |
B15 | Mehran (2021) | United kingdom | RCT | Migraine Pt | 80 | Acupuncture | • Independent t-test • χ2 test • RMANOVA • ANCOVA | • Frequency of migraine • Duration of mifraine • Pain score • Nausea • Vomiting | • VAS • Satisfaction survey | • Moderate quality • (4/5 criteria met) |
B16 | Melissa (2022) | Netherlands | RCT | Depression and anxiety Pt | 59 | Cognitive behavioral therapy | • Linear mixed model | • Depression • Anxiety • Stress | • Depression Anxiety Stress Scale—21 | • High quality • (5/5 criteria met) |
B17 | Naomi (2023) | United states of america | RCT | Anxiety Pt | 226 | Yoga, Cognitive behavioral therapy and stress education | • Generalized linear mixed model • Mediation effect model | • Response rate | • Clinical global impression–improvement scale • Meta-cognition questionnaire • Five facet mindfulness questionnaire | • High quality • (5/5 criteria met) |
B18 | Rima (2019) | Netherlands | RCT | Arthritis Pt | 72 | Yoga | • Independent t-test • ANOVA • wilcoxon • Mann–Whitney U test • Fisher’s exact test • Correlation | • Arthritis | • Disease activity score 28 • Erythrocyte sedimentation rate • Health assessment questionnaire disability index • Beck depression inventory II scale • C-reactive protein • Interleukin-6 • Tumor necrosis factor-alpha | • Moderate quality • (4/5 criteria met) |
B19 | Seung (2023) | United states of america | Descriptive | PTSD soldier Pt | NA | Acupuncture | • Qualitative Analysis | • PTSD symptom | • PTSD diagnosis index | • High quality • (5/5 criteria met) |
B20 | Xuan (2022) | United states of america | RCT | Depression and insomnia Pt | 270 | Acupuncture (electro acupuncture) | • Linear mixed model • ANOVA • Bonferroni | • Sleep • Depression • Anxiety • Insomnia | • Pittsburgh sleep quality index • Hamilton depression scale • Self-rating anxiety scale • Insomnia severity index • Actigraphy-sleep | • High quality • (5/5 criteria met) |
B21 | Xuan (2023) | United kingdom | RCT | Depression and sleep disorder Pt | 270 | Acupuncture (electro acupuncture) | • Descriptive • ANOVA • ANCOVA • RM ANOVA | • Depression • Sleep | • Pittsburgh sleep quality index • Actigraphy-sleep • Hamilton rating scale for depression • Self-rating anxiety scale • Treatment emergent symptom scale | • High quality • (5/5 criteria met) |
B22 | Yuan (2023) | United kingdom | RCT | Gallbladder stone Pt | 86 | Acupuncture | • ANOVA • RMANOVA • Regression | • Pain intensity • Time points • Gastrointestinal symptoms • Anxiety during pain | • NRS • VAS • Pain anxiety symptoms Scale-20 • Fear of pain questionnaire-III • Pain catastrophizing scale • Acupuncture expectancy scale • Chinese version of the modified massachusetts general hospital acupuncture sensation scale | • High quality • (5/5 criteria met) |